Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Arexvy
Arexvy
GSK, Pfizer RSV Shots Must Warn About Rare Paralysis Risk
Mint
Tue, 01/7/25 - 06:56 pm
GSK
Pfizer
vaccines
RSV
Guillain-Barré Syndrome
Arexvy
Abrysvo
GSK’s RSV vaccine approved in Canada for adults aged 50 to 59
Pharmaceutical Technology
Wed, 11/6/24 - 08:04 pm
GSK
Canada
Arexvy
vaccines
RSV
GSK tries to steady the ship as Arexvy sales plummet in wake of CDC guidance changes
Fierce Pharma
Wed, 10/30/24 - 11:47 am
GSK
earnings
Arexvy
RSV
vaccines
GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults
Fierce Pharma
Thu, 10/24/24 - 10:58 am
GSK
Arexvy
vaccines
RSV
Pfizer
FDA
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
Fierce Pharma
Wed, 09/18/24 - 11:54 am
GSK
RSV
vaccines
CDC
Arexvy
Shingrix
GSK gets EU okay for RSV shot in younger age group
Pharmaphorum
Thu, 08/29/24 - 11:05 am
GSK
Europe
vaccines
RSV
Arexvy
GSK exec lauds 'great start' to RSV vaccine uptake as Arexvy nabs label expansion in adults 50-59
Fierce Pharma
Sat, 06/8/24 - 01:05 pm
GSK
Arexvy
vaccines
FDA
RSV
GSK's Arexvy maintains its RSV market dominance, looks to key label expansion as Moderna's mRNA threat looms
Fierce Pharma
Wed, 05/1/24 - 11:07 pm
GSK
RSV
vaccines
Pfizer
Arexvy
Abrysvo
GSK reports positive news on trio of high-profile products
Medical Marketing and Media
Wed, 02/7/24 - 09:13 pm
GSK
Arexvy
RSV
Abrysvo
Blenrep
GSK’s Arexvy Leads Over Pfizer’s Abrysvo in Year One of RSV Vaccine Market Battle
Xtalks
Mon, 02/5/24 - 11:12 pm
GSK
Pfizer
RSV
Arexvy
Abrysvo
vaccines
GSK confirms Arexvy is a blockbuster but says the RSV battle has just begun
Fierce Pharma
Wed, 01/31/24 - 11:49 am
GSK
Pfizer
RSV
vaccines
Arexvy
GSK RSV vaccine achieves blockbuster status in just over six months
Tip Ranks
Mon, 01/29/24 - 10:30 pm
GSK
RSV
vaccines
Arexvy
Pfizer
13 Therapies Make Clarivate’s 2024 Drugs to Watch List
BioSpace
Wed, 01/10/24 - 06:30 pm
Clarivate
Eylea
Tarpeyo/Kinpeygo
Dato-DXd
Altuviiio
RPL554
exa-cel
lovo-cel
LY-3074828
Akeega
Abrysvo
Talvey
Arexvy
IMAB362
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster Status
BioSpace
Fri, 12/1/23 - 11:30 am
GSK
Pfizer
RSV
vaccines
Arexvy
GSK outpaces Pfizer in RSV vaccine market
BioPharma Dive
Wed, 11/1/23 - 11:19 am
GSK
Pfizer
vaccines
RSV
Arexvy
Abrysvo
GSK Touts Strong Q3 Performance on the Back of Arexvy, Shingrix Sales
BioSpace
Wed, 11/1/23 - 11:13 am
GSK
earnings
Arexvy
Shingrix
GSK targets younger age group with RSV vaccine Arexvy
Pharmaphorum
Wed, 10/25/23 - 09:43 am
GSK
RSV
Arexvy
vaccines
GSK stays a step ahead in RSV vaccine battle as Arexvy becomes available at US pharmacies
Fierce Pharma
Thu, 08/17/23 - 07:50 pm
GSK
RSV
vaccines
Arexvy
Pfizer
Moderna Therapeutics
GSK Expects Slower Uptake of RSV Vaccine Amid Record Sales for Shingles Shot
BioSpace
Wed, 07/26/23 - 11:40 am
GSK
earnings
vaccines
RSV
Arexvy
GSK’s RSV vaccine wins European approval
Stat
Wed, 06/7/23 - 09:59 am
GSK
RSV
Europe
vaccines
Arexvy
Pages
1
2
next ›
last »